Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01088048
Brief Title: Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

First Submitted : March 12, 2010
First Submitted that Met QC Criteria : March 15, 2010
First Posted : March 17, 2010 (Estimate)

Results First Submitted : January 11, 2021
Results First Submitted that Met QC Criteria : February 22, 2021
Results First Posted : March 18, 2021

Last Update Submitted that Met QC Criteria : February 22, 2021
Last Update Posted : March 18, 2021